Journal article icon

Journal article

A deep-learning system predicts glaucoma incidence and progression using retinal photographs

Abstract:
BackgroundDeep learning has been widely used for glaucoma diagnosis. However, there is no clinically validated algorithm for glaucoma incidence and progression prediction. This study aims to develop a clinically feasible deep-learning system for predicting and stratifying the risk of glaucoma onset and progression based on color fundus photographs (CFPs), with clinical validation of performance in external population cohorts. MethodsWe established data sets of CFPs and visual fields collected from longitudinal cohorts. The mean follow-up duration was 3 to 5 years across the data sets. Artificial intelligence (AI) models were developed to predict future glaucoma incidence and progression based on the CFPs of 17,497 eyes in 9346 patients. The area under the receiver operating characteristic (AUROC) curve, sensitivity, and specificity of the AI models were calculated with reference to the labels provided by experienced ophthalmologists. Incidence and progression of glaucoma were determined based on longitudinal CFP images or visual fields, respectively. ResultsThe AI model to predict glaucoma incidence achieved an AUROC of 0.90 (0.81-0.99) in the validation set and demonstrated good generalizability, with AUROCs of 0.89 (0.83-0.95) and 0.88 (0.79-0.97) in external test sets 1 and 2, respectively. The AI model to predict glaucoma progression achieved an AUROC of 0.91 (0.88-0.94) in the validation set, and also demonstrated outstanding predictive performance with AUROCs of 0.87 (0.81-0.92) and 0.88 (0.83-0.94) in external test sets 1 and 2, respectively. ConclusionOur study demonstrates the feasibility of deep-learning algorithms in the early detection and prediction of glaucoma progression. FUNDINGNational Natural Science Foundation of China (NSFC); the High-level Hospital Construction Project, Zhongshan Ophthalmic Center, Sun Yat-sen University; the Science and Technology Program of Guangzhou, China (2021), the Science and Technology Development Fund (FDCT) of Macau, and FDCT-NSFC.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1172/jci157968

Authors

More by this author
Role:
Author
ORCID:
0000-0001-6211-6306
More by this author
Role:
Author
ORCID:
0000-0001-5030-4852
More by this author
Role:
Author
ORCID:
0000-0002-1760-237X
More by this author
Role:
Author
ORCID:
0009-0009-1754-7516
More by this author
Role:
Author
ORCID:
0000-0003-3106-6945



Publisher:
American Society for Clinical Investigation
Journal:
The Journal of Clinical Investigation More from this journal
Volume:
132
Issue:
11
Pages:
e157968
Article number:
e157968
Publication date:
2022-05-31
DOI:
EISSN:
1558-8238
ISSN:
0021-9738


Language:
English
Keywords:
Pubs id:
1261913
Local pid:
pubs:1261913
Source identifiers:
W4281747382
Deposit date:
2026-04-24
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP